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Summary
Background: Several studies have reported reduced heart rate variability (HRV) in
patients with chronic epilepsy under treatment with antiepileptic drugs. This impair-
ment in cardiac autonomic control might be of relevance in relation to the risk of
sudden unexpected death in patients with chronic refractory epilepsy. Little informa-
tion is, however, available on HRV in untreated patients with newly diagnosed
epilepsy.
Methods: We used spectral analysis to assess HRV based on 24 h ambulatory EKG
recordings in 22 consecutive untreated patients with epilepsy (15 with localization-
related, 4 with generalized idiopathic and 3 with undetermined epilepsy). The HRV in
these patients was compared with 22 age and sex matched healthy controls.
Results: When analysing the full 24 h recordings, there were no significant difference
between the patients and the controls in any of the analyzed measures of HRV:
standard deviation of RR-intervals (P = 0.191), total power (P = 0.170), very low
frequency power (P = 0.329), low frequency power (LF) (P = 0.161), high frequency
power (HF) (P = 0.186) and the LF/HF ratio (P = 0.472). The results were very similar
for daytime and nighttime recordings.
Conclusion: Our results suggest that there is no major effect of epilepsy as such on
HRV in patients with untreated epilepsy. It should be emphasized that this study
assessed newly diagnosed patients and that the results may not be applicable to
patients with chronic epilepsy.
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Impairment of autonomic cardiac control has been
discussed as a possible contributing mechanism for
sudden unexpected death in epilepsy (SUDEP).1,2. Published by Elsevier Ltd. All rights reserved.
HRV in epilepsy patients without treatment 505Autonomic cardiac control can be assessed clinically
by analysis of heart rate variability (HRV) based on
EKG recordings.3,4 HRV is of special interest in the
contextof SUDEP sincea reducedHRVhasbeen shown
to predict mortality and more specifically sudden
death in other conditions than epilepsy, e.g. conges-
tive heart failure, diabetic neuropathy, after acute
myocardial infarction and stroke5—9 and is according
to preliminary observations possibly also amarker for
an increased risk of SUDEP.10 Several studies have
reported reduced HRV in patients with newly diag-
nosedepilepsy11 orwith chronicepilepsyunder treat-
ment with antiepileptic drugs.12—16 These studies
were, however, not designed to distinguish between
the effects of epilepsy as such from those of the
ongoing drug treatment.
The contribution of the epilepsy per se to the
impaired autonomic cardiac control remains to be
evaluated.17,18 In particular data onHRV in untreated
newly diagnosed epilepsy patients is scarce. To date
there is only one published report comparing HRV in
untreated epilepsy with normal controls. This study
from Turkey reported increased sympathetic control
of HRV in highly selected young patients with unspe-
cified generalized tonic—clonic seizures compared
with healthy controls,19 but further studies of more
representative and better characterized epilepsy
patients are needed. The aim of this study was to
investigate HRV in patients with untreated epilepsy
and to assess the effect of epilepsy per se.Patients and methods
Patients
Adult patients with newly diagnosed epilepsy
attending the Department of Neurology at the Kar-
olinska Hospital in Stockholm, Sweden, were eligi-
ble for inclusion in the study. Only patients without
antiepileptic drugs (AEDs) were included. Patients
with a history of heart failure, coronary heart dis-
ease, diabetes, uraemia or any other known disease
that might affect the autonomic nervous system
were excluded, as were patients with brain tumours
and those for which immediate treatment with AEDs
was considered necessary. Patients using medication
known to affect the heart rate or blood pressure
were excluded.
Controls
For each patient one healthy control subject was
selected matched for age and sex. The controls
were selected from a bank of previously recorded
healthy volunteers.Methods
The patients with epilepsy and their controls had an
ambulatory 24 h digital EKG recording during which
they were free to practice their normal daily activ-
ities. They were asked to keep a seizure-diary during
the recordings.
QRS-complexes were classified by automatic ana-
lysis of the digitally recorded EKG signal. The con-
secutive RR-intervals and the corresponding
classification code were exported to an ASCII text
file. For the frequency domain analysis 5 min epochs
of data were analysed by custom made software.
The time series of RR-intervals were re-sampled at a
frequency of two samples/s (2 Hz). Gaps in the time
series due to non-normal RR-intervals (QRS-labelled
by the Aspect System classification as noise or ecto-
pic beats) were filled with values calculated by
linear interpolation between the adjacent normal
RR-intervals. The computer program checked for
misclassified drop beats deviating more than three
S.D.s from the mean normal RR-interval of each
epoch. Epochs with more than 4% of non-normal
RR-intervals were excluded from further analysis. At
least 50% of a 24 h recording had to be analyzable for
a tape to be included, in accordance with issued
guidance.4 All together a maximum of 288 epochs
were thus analyzed per patient, representing both
active and resting periods. The frequency domain of
the time series of RR-intervals was analyzed with an
auto regression method.20 The mean RR-interval of
each time series was subtracted and then detrended
by applying linear regression. The power spectrum
of the frequency domains was divided into four
different frequency bands: total power (TP)
0.0033—0.40 Hz (ms2); very low frequency power
(VLF), 0.0033—0.04 Hz (ms2); low frequency power
(LF), 0.04—0.15 Hz (ms2); high frequency power
(HF), 0.15—0.40 Hz (ms2). From the power, we cal-
culated the LF/HF ratio as an index of the balance
between sympathetic and parasympathetic influ-
ences on HR.21 HF reflects respiratory sinus arrhyth-
mia and is mainly related to parasympathetic
activity.21—23 LF oscillations are associated with
baroreflexor control of sympathetic activity21,22,24
but parasympathetic activity might also influence
LF.25
In the time domain, the mean of the standard
deviations of all normal RR-intervals for all 5 min
segments of a 24 h EKG recording (SDRR) was calcu-
lated. All analyses were first made for the full 24 h
period. Separate analyses were thereafter made for
nighttime (00:00 a.m. to 05:00 a.m.) and daytime
(07:30 a.m. to 09:30 p.m.), respectively.
A non-paired t-test was used to compare HRV
data between patients and controls. Significance
506 H. Persson et al.was assumed for P-values < 0.05. Stata 7.0 software
was used for data analysis (Stata Corporation, USA).
The study was approved by the institutional
review board and all patients and healthy subjects
gave their informed consent.Results
We enrolled 24 consecutive adult patients with
newly diagnosed epilepsy. Two patients with con-
comitant diseases known to affect the autonomic
nervous system or a history of cardiac diseases
were excluded. In total 22 patients (13 female/9
male) were thus included in the study. Patient
characteristics are summarized in Table 1. TheTable 1 Characteristics at the time of EKG recording of th
Patient
no.
Sex/age
(years)
Seizure
typesa
Epilepsy
typesb
Durationc
1 F/31 CPS LC 4 y
2 F/27 CPS LC 3 y
3 F/63 CPS LS 3 y
4 F/37 GTCS + SPS LS 10 y
5 M/72 CPS LC 3 m
6 F/69 GTCS U 1.5 m
7 M/76 CPS LS 4 d
8 M/27 GTCS + CPS LC 5 y
9 M/32 GTCS + CPS LS 10 y
10 M/34 GTCS LS 2 d
11 F/56 GTCS LC 11 m
12 M/43 GTCS LC 1 y
13 F/72 GTCS U 5 y
14 F/33 GTCS + SPS LS 5 m
15 F/24 CPS LC 5 y
16 M/26 CPS LS 1.5 y
17 F/18 Absence GI 4 y
18 M/23 GTCS + Absence GI 2 m
19 F/32 GTCS + Myoclon GI 6 m
20 F/37 GTCS U 17 y
21 F/19 CPS LC 7 m
22 M/33 GTCS GI 20 y
a GTCS: generalized tonic—clonic seizures, CPS: complex partial
b LS: localization-related symptomatic, LC: localization-related c
c Time from first seizure of the patient to enrolment in study yeamedian age was 33 years (18—76), and the median
time from their first seizure to enrolment in the
study 27 months (2 days to 20 years). Fifteen of
the patients had localization-related, four gener-
alized idiopathic and three undetermined epi-
lepsy.
Twenty-two patients with newly diagnosed epi-
lepsy, without AED, and 22 healthy controls were
thus examined. All patients had been seizure free at
least 24 h before the EKG recording and none
reported seizures during the recording. There was
no significant difference in any of the HRV measures
between the patients and their controls whether the
whole 24 h registration periods were compared or
nighttime and daytime recordings were analyzed
separately (Table 2).e 22 untreated patients with epilepsy
Neuroradiology EEG
Normal (MRI) Normal
Normal (MRI) Epileptiform activity,
bilateral
Dural fistula left
occipital lobe (CT)
Non-epileptiform abnormal
activity, left frontotemporal
Normal (MRI) Normal
Normal (CT) Non-epileptiform abnormal
activity, left temporal
Normal (CT) Non-epileptiform abnormal
activity, bilateral
Hypodensity left
temporal lobe (CT)
Non-epileptiform abnormal
activity, left frontotemporal
Normal (MRI) Epileptiform activity, left
frontotemporal
Unspecific white
object left (MRI)
Normal
Cavernoma right
temporal lobe (MRI)
Non-epileptiform abnormal
activity, left temporal
Normal (CT) Normal
Normal (MRI) Normal
Normal (CT) Normal
Hypodensity right
occipital lobe (CT)
Epileptiform activity, right
parietal
Normal (MRI) Normal
Cavernoma of the
left insula (MRI)
Non-epileptiform abnormal
activity, bilateral
Normal (MRI) Epileptiform activity, bilateral
Normal (CT) Not completed
Normal (CT) Normal
Normal (CT) Normal
Normal (MRI) Non-epileptiform abnormal
activity, left frontotemporal
Normal (MRI) Epileptiform activity, bilateral
seizures, SPS: simple partial seizures.
ryptogenic, GI: generalized idiopathic, U: undetermined.
rs/months/days.
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In this study on 22 patients with untreated epilepsy
we could not demonstrate any statistically signifi-
cant difference in any of the analysed parameters,
SDRR, TP, VLF, LF, HF or LF/HF compared to age and
sex matched healthy controls. We cannot exclude
that the lack of significance was due to the small
number of patients and limited statistical power
(52% power for a difference in LF with a P < 0.05
level). It is also possible that the broad range of
epilepsy and the heterogeneity of seizure types may
have affected our results.
However, our patients reflect the normal spec-
trum of patients with adult epilepsy and they were
well classified using seizure-semiology, EEG and
neuroradiology.
ATurkish study has recently reported reduced HF,
increased LF and consequently an increased LF/HF
ratio in 42 young men (military recruits) with newly
diagnosed generalized tonic—clonic seizures com-
pared with healthy controls.19 These patients, how-
ever, cannot be considered representative of new
onset epilepsy in general. The mean frequency of
generalized tonic—clonic seizures among these
patients was 8 attacks/year for an average of 5.6
years before diagnosis. Consequently, they had suf-
fered a high number of major seizures before they
were included in the study. Furthermore, the study
failed to classify the type of seizures, partial or
generalized, and epilepsy, partly since the patients
were not subjected to an EEG examination.
In our present study, we could not confirm the
findings from the study of Evrengul et al.19 In con-
trast, HRV measures in our patients with newly diag-
nosed epilepsywerenot different in any respect from
the results obtained in the age and sex matched
healthy controls but the trends in our study suggests
lower LF and LF/HF ratio rather than the opposite as
in the study of Evrengul et al.19. In addition to dis-
similarities in patient selection andcharacterization,
there are methodological differences that can con-
tribute to the divergent outcomes of the two studies.
In order to qualify for inclusion in the Turkish study,
patients had to stay in hospital until they had a
seizure recorded on a video-surveillance in the hos-
pital department. The patients had thus been hospi-
talized for 42  11 (mean  S.D.) days before the
EKG recordings. Although it seems unlikely, it is
unclear if the controls had been subjected to the
same procedure. In our study, the procedures for
assessment of HRV were the same for patients and
controls, an ambulatory 24 h EKG recording.
In conclusion, we could not demonstrate any
significant difference in HRV measures between
our patients with untreated newly diagnosed
508 H. Persson et al.epilepsy and matched healthy controls. This obser-
vation needs to be interpreted with some caution
because of the limited number of included patients
and the non-significant apparent trend towards
lower HRV measures among the patients (Table 2).
Our results, however, suggest that there is no major
effect of the epilepsy as such on HRV in patients with
newly diagnosed epilepsy. It should be emphasized
that this study assessed newly diagnosed patients
and that the results may not be applicable to
patients with chronic epilepsy. Further studies are
needed to assess the effect of epilepsy per se in
patients with untreated epilepsy; such a study
should be performed on larger patient groups in
patients with well classified epilepsy with age and
sex matched healthy controls.Acknowledgement
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